Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Deals

Illumina-Grail drama escalates as EC argues breach of merger regulation

August 20, 2021 8:23 PM UTC

Illumina is headed to the European courts over its completed acquisition of Grail as the European Commission asserts that closing the deal has breached the bloc’s merger regulation prior to completion of its review.

Arguing that the EU review and legal process will push beyond the deal’s expiration date in December, Illumina went forward with completing its $8 billion acquisition of Grail Inc. on Wednesday, noting that the withdrawal of the U.S. Federal Trade Commission’s lawsuit provided no impediment to the deal closing...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article